Skip to content
10-Q

Quarterly Report

OPIANT PHARMACEUTICALS, INC.

0001385508-22-000121

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 8, 2022 5.16M sh
Shares Diluted Q2 2022 · Jun 30, 2022 5.09M sh
Shares Diluted Q2 2022 · Jun 30, 2022 5.05M sh
Shares Diluted Q2 2022 · Jun 30, 2021 5.43M sh
Shares Diluted Q2 2022 · Jun 30, 2021 4.31M sh
Capex Q2 2022 · Jun 30, 2022 $7.88K
Capex Q2 2022 · Jun 30, 2021 $0
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$12.73M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$363.45K
Long Term Debt Q2 2022 · Jun 30, 2022 $13.7M
Long Term Debt Q2 2022 · Dec 31, 2021 $16.1M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $40.17M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $37.85M
Stockholders Equity Q2 2022 · Jun 30, 2022 $29.6M
Stockholders Equity Q2 2022 · Mar 31, 2022 $39.26M
Stockholders Equity Q2 2022 · Dec 31, 2021 $46.84M
Stockholders Equity Q2 2022 · Jun 30, 2021 $36.36M
Stockholders Equity Q2 2022 · Mar 31, 2021 $33.99M
Stockholders Equity Q2 2022 · Dec 31, 2020 $35.49M
Current Liabilities Q2 2022 · Jun 30, 2022 $4.99M
Current Liabilities Q2 2022 · Dec 31, 2021 $6.85M
Total Liabilities Q2 2022 · Jun 30, 2022 $19.23M
Total Liabilities Q2 2022 · Dec 31, 2021 $23.59M
Current Assets Q2 2022 · Jun 30, 2022 $47.76M
Current Assets Q2 2022 · Dec 31, 2021 $69.16M
Total Assets Q2 2022 · Jun 30, 2022 $48.82M
Total Assets Q2 2022 · Dec 31, 2021 $70.43M
Eps Diluted Q2 2022 · Jun 30, 2022 −$2.31
Eps Diluted Q2 2022 · Jun 30, 2022 −$4.74
Eps Diluted Q2 2022 · Jun 30, 2021 $0.31
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.27
Eps Basic Q2 2022 · Jun 30, 2022 −$2.31
Eps Basic Q2 2022 · Jun 30, 2022 −$4.74
Eps Basic Q2 2022 · Jun 30, 2021 $0.39
Eps Basic Q2 2022 · Jun 30, 2021 −$0.27
Sga Expense Q2 2022 · Jun 30, 2022 $4.01M
Sga Expense Q2 2022 · Jun 30, 2022 $8.34M
Sga Expense Q2 2022 · Jun 30, 2021 $2.73M
Sga Expense Q2 2022 · Jun 30, 2021 $5.38M
Rd Expense Q2 2022 · Jun 30, 2022 $7.92M
Rd Expense Q2 2022 · Jun 30, 2022 $16.74M
Rd Expense Q2 2022 · Jun 30, 2021 $3.15M
Rd Expense Q2 2022 · Jun 30, 2021 $7.24M
Net Income Q2 2022 · Jun 30, 2022 −$11.74M
Net Income Q2 2022 · Jun 30, 2022 −$23.92M
Net Income Q2 2022 · Mar 31, 2022 −$12.19M
Net Income Q2 2022 · Jun 30, 2021 $1.68M
Net Income Q2 2022 · Jun 30, 2021 −$1.16M
Net Income Q2 2022 · Mar 31, 2021 −$2.84M
Operating Income Q2 2022 · Jun 30, 2022 −$11.37M
Operating Income Q2 2022 · Jun 30, 2022 −$23.15M
Operating Income Q2 2022 · Jun 30, 2021 $2.25M
Operating Income Q2 2022 · Jun 30, 2021 −$78.14K
Revenue Q2 2022 · Jun 30, 2022 $3.89M
Revenue Q2 2022 · Jun 30, 2022 $8.36M
Revenue Q2 2022 · Jun 30, 2021 $11.26M
Revenue Q2 2022 · Jun 30, 2021 $17.65M